Cargando…
Molecularly Characterised Xenograft Tumour Mouse Models: Valuable Tools for Evaluation of New Therapeutic Strategies for Secondary Liver Cancers
To develop and evaluate new therapeutic strategies for the treatment of human cancers, well-characterised preclinical model systems are a prerequisite. To this aim, we have established xenotransplantation mouse models and corresponding cell cultures from surgically obtained secondary human liver tum...
Autores principales: | Mischek, Daniela, Steinborn, Ralf, Petznek, Helga, Bichler, Christoph, Zatloukal, Kurt, Stürzl, Michael, Günzburg, Walter H., Hohenadl, Christine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655652/ https://www.ncbi.nlm.nih.gov/pubmed/19300524 http://dx.doi.org/10.1155/2009/437284 |
Ejemplares similares
-
Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer
por: Hlavaty, Juraj, et al.
Publicado: (2012) -
Mouse Mammary Tumor Virus Promoter-Containing Retroviral Promoter Conversion Vectors for Gene-Directed Enzyme Prodrug Therapy are Functional In Vitro and In Vivo
por: Klein, Reinhard, et al.
Publicado: (2008) -
Valuable Secondary Metabolites from Fungi
por: Demain, Arnold L.
Publicado: (2014) -
Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
por: Meneceur, Sarah, et al.
Publicado: (2020) -
Characterisation of Human Tumours
por: Bazill, G. W.
Publicado: (1976)